• Reported GAAP EPS of $1.37 up 2.24% YoY • Reported revenue of $2.4B up 6.25% YoY • Xylem initiates full-year 2026 revenue guidance of $9.1B, representing 2% to 4% organic growth, and adjusted EBITDA margin is expected to be 22.9% to 23.3 percent.
Bullish
Xylem achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, driven by strong fourth-quarter performance and healthy organic growth, positioning the company for sustainable growth.
Bearish
Xylem's net income margin decreased, partly due to increased restructuring and realignment costs. The company also faces risks from supply chain disruptions, rising operating costs, and market competition.